This is the authors' abstract. We don't add key points for this paper.
Transgenic tobacco with RuBP-limited photosynthetic assimilation due to a 95% reduction in phosphoribulokinase activity, had higher specific activities of Rubisco in fresh extracts and after full activation, than in the wild type. Differences in the amounts of a daytime tight-binding inhibitor were sufficient to contribute significantly to these activity differences.
No takes yet. Share an insight, caveat, or question.
Paul et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: